Patents by Inventor Jean S. Marshall

Jean S. Marshall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating type I hypersensitivity using monophosphoryl lipid A
    Patent number: 5762943
    Abstract: Methods and compositions for treating type I immunoglobin E (IgE)-dependent hypersensitivity by the administration of monophosphoryl lipid A (MLA) or 3-deacylated monophosphoryl lipid A (3D-MLA) are disclosed. MLA or 3D-MLA administered alone or in combination with an allergen to a patient suffering from type I hypersensitivity reduces levels of total or allergen specific IgE and increases levels of IgG antibody in that patient. MLA and 3D-MLA can be administered as part of a desensitization regimen or as a component of a prophylactic vaccine to prevent a type I hypersensitivity reaction.
    Type: Grant
    Filed: May 14, 1996
    Date of Patent: June 9, 1998
    Assignee: Ribi ImmunoChem Research, Inc.
    Inventors: Jerry Dolovich, J. Terry Ulrich, Jean S. Marshall